Inventor · disambiguated record
Marc Weinberg
Also filed as: WEINBERG MARC · WEINBERG MARC S · WEINBERG MARC SAUL
9 granted patents·9 pending applications·75 citations·filing 1983–2024
84Inventor score
Files withHOPE CITY4UNIV NORTH CAROLINA CHAPEL HILL4ARBUTHNOT PATRICK2VERTEX PHARMA2CHARLES STARK DRAPER LABORATORY INC1
Top patents by PatentIndex Score
18 records- 0195US9605266B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2015·Granted Mar 28, 2017·24 cites·12 claims
- 0291US10167474B2Cell-specific internalizing RNA aptamers against human CCR5 and uses thereforeHOPE CITY·Filed 2017·Granted Jan 1, 2019·6 cites·18 claims
- 0385US2025382569A1Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 0485US2025382635A1Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 0576US4566458AThorax protectorWEINBERG MARC S·Filed 1983·Granted Jan 28, 1986·43 cites·12 claims
- 0674US2022288141A1Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2021·Application pending·0 cites
- 0765US2019224256A1Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cellsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Application pending·0 cites
- 0864US2023242627A1Composition and method for activating latent human immunodeficiency virus (hiv)HOPE CITY·Filed 2023·Application pending·0 cites
- 0961US9365647B2Compounds for use in the treatment of Alzheimer's diseaseWEISS STEFAN FRANZ THOMAS·Filed 2012·Granted Jun 14, 2016·1 cites·4 claims
- 1056US11618780B2Composition and method for activating latent human immunodeficiency virus (HIV)HOPE CITY·Filed 2018·Granted Apr 4, 2023·0 cites·12 claims
- 1151US8293974B2Use of double stranded RNA hairpin duplexes in gene silencingARBUTHNOT PATRICK·Filed 2008·Granted Oct 23, 2012·1 cites·12 claims
- 1250US2003078190A1Methods for tissue protection using highly effective inhibition of the renin-angiotensin systemFiled 2002·Application pending·0 cites
- 1347US12269804B2Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiencyVERTEX PHARMA·Filed 2019·Granted Apr 8, 2025·0 cites·8 claims
- 1446US12121524B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Oct 22, 2024·0 cites·36 claims
- 1546US2016361413A1Compounds for use in the treatment of alzheimer's diseaseUNIV JOHANNESBURG WITWATERSRAND·Filed 2016·Application pending·0 cites
- 1645US10596267B2Method and process for quantitative evaluation of pharmacokinetics, therapeutic effects and safety of delivery of drug compounds to the inner ear for treatment of auditory diseaseCHARLES STARK DRAPER LABORATORY INC·Filed 2017·Granted Mar 24, 2020·0 cites·18 claims
- 1742US2010184840A1Primary micro rna expression cassetteUNIV WITWATERSRAND·Filed 2009·Application pending·0 cites
- 1837US2008207539A1Self-Processing Rna Expression CassetteARBUTHNOT PATRICK·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Weinberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →